Geron Corporation ( GERN) - Stock Earnings
GERN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -18.4 million USD | 47.2 million USD |
| 2025Q4 | -31.1 million USD | 48.0 million USD |
| 2026Q1 | -3.6 million USD | 51.8 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GERN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -184.1 million USD | 237000 USD |
| 2024 | -174.6 million USD | 77.0 million USD |
| 2025 | -85.8 million USD | 183.9 million USD |
| 2026 Est. | — | — |
GERN
Price: $1.17
52 week price:
Earnings Per Share: -0.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 535483
Ebitda: -6.9 millionMarket Capitalization: 744.2 million